Skip to Content
Pharmaceutical company Merck fell six spots on the list in its first year with CEO Robert Davis at the helm. But that modest slide masks a successful year in which profits jumped 85%, to $13 billion. Excluding revenue from Organon, the women’s health company whose spinoff was completed in June 2021, Merck’s sales overall increased 17%, including a 20% gain for the company’s hallmark cancer drug Keytruda and a 44% increase in sales for HPV vaccine Gardasil. Merck also registered nearly $1 billion in sales for molnupiravir, an oral antiviral treatment for COVID that received emergency use authorization from the FDA in December 2021. 
Courtesy of Merck
Lists ranking Merck
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MOREview in list
35 Best Large Workplaces in New York - 2022The companies on this year's list stand out for ce...READ MOREview in list
Fortune 500 - 2022This year’s Fortune 500 marks the 68th running of ...READ MOREview in list
World’s Most Admired Companies - 2022Just as it dominates our economy, Big Tech now dom...READ MOREview in list
100 Best Companies to Work For - 2021Our 2021 list of the 100 best companies to work fo...READ MOREview in list
Change the World - 2020As we face unprecedented collective challenges, co...READ MOREview in list